Producing safe, quality medicines has always been a fundamental business necessity at BTG and last year the role of Head of Quality was created, reporting directly to the CEO.
All of our products and medicines are developed, tested and distributed according to the standard of good practice required by pharmaceutical regulators. We only appoint Clinical Research Organisations, Contract Manufacturing Organisations and other third party vendors that have high standard of ethics and quality and comply with good practice guidance.
We operate compassionate use and named patient programmes to ensure that physicians are able to access our emergency medicines for their patients in territories where they have not yet received regulatory approval.
In October 2010, we will assume responsibility for selling and marketing CroFab™ and DigiFab™ in the US. To support preparations in advance of this important company milestone, we have successfully attracted new talent to the US-based commercial team in the fields of sales, marketing and medical affairs. To improve our relationship with our customers we aim to capitalise on this new expertise. Several targets have been identified for completion during the next year including the development of a new Sales and Marketing Code of Conduct and a hotline for sales to incorporate ethical and compliance issues such as adverse events reporting. In addition, during the coming year we aim to roll out a certification process for all employees on compliance in sales and marketing activities.
We’re also considering the development of a National Emergency Programme to supply product free of cost to areas where there may be a national emergency.
2010/11 Targets
-
Update the Code of Conduct to incorporate a new Sales and Marketing Code of Conduct.
-
Roll out a certification process for all employees on compliance.
-
Develop a hotline for sales early in the next financial year to incorporate ethical and compliance issues such as adverse events reporting and customer complaints.
-
Devise an appropriate questionnaire incorporating CR questions to provide evidence of the level of ethical, quality and compliance practices of BTG’s contractors
|